29 May 2022 , 04:02 PM
Net profit of Colinz Laboratories rose 16.67% to Rs 0.07 crore in the quarter ended March 2022 as against Rs 0.06 crore during the previous quarter ended March 2021. Sales declined 3.66% to Rs 1.58 crore in the quarter ended March 2022 as against Rs 1.64 crore during the previous quarter ended March 2021. For the full year,net profit rose 61.90% to Rs 0.34 crore in the year ended March 2022 as against Rs 0.21 crore during the previous year ended March 2021. Sales rose 13.15% to Rs 6.97 crore in the year ended March 2022 as against Rs 6.16 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 1.58 | 1.64 | -4 | 6.97 | 6.16 | 13 |
OPM % | 6.96 | 3.66 | – | 8.46 | 5.52 | – |
PBDT | 0.17 | 0.11 | 55 | 0.68 | 0.44 | 55 |
PBT | 0.12 | 0.06 | 100 | 0.48 | 0.25 | 92 |
NP | 0.07 | 0.06 | 17 | 0.34 | 0.21 | 62 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.